Clonorchis sinensis dopamine transporter (CsDAT) facilitates dopamine uptake
Wang-Jong Lee1,2, Sung-Jun Kim3, Woon Kyu Lee4
1Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Korea.
Parasites, Hosts and Diseases
|September 1, 2025
Summary
This study characterized the Clonorchis sinensis dopamine transporter (CsDAT), finding it efficiently transports dopamine. Its unique structure and inhibitor binding offer potential for new clonorchiasis treatments.
Area of Science:
- Parasitology
- Neuroscience
- Biochemistry
Background:
- Clonorchis sinensis causes clonorchiasis, a liver fluke infection linked to hepatobiliary diseases in East Asia.
- Dopamine, a neurotransmitter, may play a role in parasite physiology and survival through uptake by trematodes.
Purpose of the Study:
- To functionally and structurally characterize the dopamine transporter (CsDAT) in C. sinensis.
- To investigate the potential of CsDAT as a therapeutic target for clonorchiasis.
Main Methods:
- Synthesized cDNA from adult C. sinensis worms and expressed CsDAT in Xenopus laevis oocytes.
- Conducted radiolabeled dopamine uptake assays and analyzed kinetic parameters.
- Constructed a 3D model of CsDAT and performed molecular docking simulations.
Main Results:
- CsDAT mediates sodium-dependent, saturable dopamine uptake with high affinity (Km = 454.5 nM).
- The 3D model revealed a conserved substrate-binding pocket with key residues interacting with dopamine.
- CsDAT exhibited higher binding affinity for dopamine and inhibitors compared to the human dopamine transporter.
Conclusions:
- CsDAT is a physiologically relevant dopamine transporter in C. sinensis.
- The distinct structural and binding properties of CsDAT suggest its potential as a specific therapeutic target for clonorchiasis, minimizing host side effects.
Keywords:
Clonorchis sinensisXenopus laevis oocytedopaminedopamine transportersolute carrier family 6 member 3uptakeMore Related Videos
Related Concept Videos
Transcellular Transport of Solutes
3.8K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.8K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
The Significance of Membrane Transport
29.4K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
29.4K
Carrier-Mediated Transport
541
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
541
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K


